New Zealand markets closed
  • NZX 50

    11,038.68
    -161.36 (-1.44%)
     
  • NZD/USD

    0.5720
    -0.0011 (-0.19%)
     
  • NZD/EUR

    0.5831
    -0.0001 (-0.02%)
     
  • ALL ORDS

    6,679.80
    -80.80 (-1.20%)
     
  • ASX 200

    6,478.20
    -76.80 (-1.17%)
     
  • OIL

    80.82
    -0.41 (-0.50%)
     
  • GOLD

    1,669.90
    +1.30 (+0.08%)
     
  • NASDAQ

    11,164.78
    -329.05 (-2.86%)
     
  • FTSE

    6,881.59
    -123.80 (-1.77%)
     
  • Dow Jones

    29,225.61
    -458.13 (-1.54%)
     
  • DAX

    11,975.55
    -207.73 (-1.71%)
     
  • Hang Seng

    17,154.48
    -11.39 (-0.07%)
     
  • NIKKEI 225

    25,873.10
    -548.95 (-2.08%)
     
  • NZD/JPY

    82.7220
    -0.0250 (-0.03%)
     

Philips to convene Extraordinary General Meeting of Shareholders to appoint Roy Jakobs as new President and Chief Executive Officer

·1-min read
Royal Philips
Royal Philips

Frans van Houten

Roy Jakobs

August 18, 2022

Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA) today convenes an Extraordinary General Meeting of Shareholders (EGM) and publishes the agenda with explanatory note. The sole purpose of the EGM is to appoint Roy Jakobs as the company’s President and Chief Executive Officer, effective October 15, 2022, as successor to Frans van Houten.

The EGM will be held at the Hotel Okura Amsterdam (Ferdinand Bolstraat 333, Amsterdam) on Friday, September 30, 2022, beginning at 09:30 am CET. The agenda with explanatory note and other information relevant for the EGM are available here.

For further information, please contact:

Ben Zwirs
Philips Global Press Office
Tel.: +31 6 1521 3446
E-mail: ben.zwirs@philips.com

Derya Guzel
Philips Investor Relations
Tel.: +31 20 59 77055
E-mail: derya.guzel@philips.com

About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and well-being, and enabling better outcomes across the health continuum – from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips generated 2021 sales of EUR 17.2 billion and employs approximately 79,000 employees with sales and services in more than 100 countries. News about Philips can be found at www.philips.com/newscenter.

Attachments